{"transactions":[{"id":712533,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-07-09T01:05:29.000Z","date":"2026-07-07","kind":"grant","planned":false,"acquired":true,"shares":118000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on May 28, 2026, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2026 Annual Meeting of Stockholders. Such stockholder approval was obtained on July 7, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from May 28, 2026, with 1/3 vesting on the first anniversary of May 28, 2026, and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of May 28, 2026"}],"balance_after":118000,"derivative":{"exercise_price":3.14,"expiration_date":"2036-05-28","underlying":"Common stock","underlying_shares":118000},"source":{"system":"sec-edgar","filing":"0001104659-26-082012","document":"tm2620095-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926082012/tm2620095-4_4seq1.xml","form_type":"4"}},{"id":784556,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants","published_at":"2026-05-12T00:07:18.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":26040,"price":0.01,"value":260.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Expiration dates are as follows: Tranche A shall have a one-year term from the date of stockholder approval; Tranche B shall have a two-year term from the date of stockholder approval; Tranche C shall have a five-year term from the date of stockholder approval."}],"balance_after":36149,"derivative":{"exercise_price":2.88,"exercise_date":"2026-05-07","underlying":"Common Stock","underlying_shares":26040},"source":{"system":"sec-edgar","filing":"0001104659-26-058854","document":"tm2614289-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926058854/tm2614289-2_4seq1.xml","form_type":"4"}},{"id":784555,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-12T00:07:18.000Z","date":"2026-05-07","kind":"purchase","planned":false,"acquired":true,"shares":8680,"price":2.88,"value":24998.4,"ownership":{"direct":true},"balance_after":20451,"source":{"system":"sec-edgar","filing":"0001104659-26-058854","document":"tm2614289-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465926058854/tm2614289-2_4seq1.xml","form_type":"4"}},{"id":1092110,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Warrants","published_at":"2025-07-03T12:01:18.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.01,"value":100.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":5.25,"exercise_date":"2025-07-02","expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-25-065572","document":"tm2519819-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065572/tm2519819-2_4seq1.xml","form_type":"4"}},{"id":1092109,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-07-03T12:01:18.000Z","date":"2025-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":4.99,"value":49900.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025."}],"balance_after":12768,"source":{"system":"sec-edgar","filing":"0001104659-25-065572","document":"tm2519819-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925065572/tm2519819-2_4seq1.xml","form_type":"4"}},{"id":1209428,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2025-03-13T01:44:18.000Z","date":"2025-01-10","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":0.28,"value":8400.0,"ownership":{"direct":true},"balance_after":83141,"source":{"system":"sec-edgar","filing":"0001104659-25-023121","document":"tm259066-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925023121/tm259066-1_4seq1.xml","form_type":"4"}},{"id":1263511,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2025-02-18T21:05:07.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from February 14, 2025, with 1/3 vesting on the first anniversary of February 14, 2026 and the remainder\nvesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of February 14, 2026."}],"balance_after":500000,"derivative":{"exercise_price":0.29,"expiration_date":"2035-02-14","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-25-014744","document":"tm256830-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465925014744/tm256830-5_4seq1.xml","form_type":"4"}},{"id":1475025,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-06-18T21:04:49.000Z","date":"2024-06-14","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on December 15, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2024 Annual Meeting of Stockholders.  Such stockholder approval was obtained on June 14, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from December 15, 2023, with 1/3 vesting on the first anniversary of Decembner 15, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of Decembner 15, 2023."}],"balance_after":500000,"derivative":{"exercise_price":2.65,"expiration_date":"2033-12-15","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001104659-24-072891","document":"tm2417520-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465924072891/tm2417520-10_4seq1.xml","form_type":"4"}},{"id":1713988,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-12-13T01:04:10.000Z","date":"2023-06-23","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"This option was contingently granted on January 16, 2023, subject to approval by Cellectar's stockholders of Cellectar's amended 2021 Stock Incentive Plan at Cellectar's 2023 Annual Meeting of Stockholders. Such stockholder approval was obtained on June 23, 2023. Because January 16, 2023 was a federal holiday, the option was priced on the following trading day."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest over a period of three years from January 17, 2023, with 1/3 vesting on the first anniversary of January 17, 2023 and the remainder vesting in 24 equal monthly installments over a 24-month period beginning on the first anniversary of January 17, 2023."}],"balance_after":144000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-23-125484","document":"tm2332764-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125484/tm2332764-4_4seq1.xml","form_type":"4"}},{"id":1713987,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2023-12-13T01:04:10.000Z","date":"2023-12-08","kind":"grant","planned":false,"acquired":true,"shares":42927,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53141,"source":{"system":"sec-edgar","filing":"0001104659-23-125484","document":"tm2332764-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923125484/tm2332764-4_4seq1.xml","form_type":"4"}},{"id":2052236,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-01-18T23:34:57.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":144000,"derivative":{"exercise_price":1.68,"expiration_date":"2033-01-17","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0001104659-23-004701","document":"tm233841-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923004701/tm233841-3_4seq1.xml","form_type":"4"}},{"id":2423962,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-01-27T21:06:19.000Z","date":"2022-01-25","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":475000,"derivative":{"exercise_price":0.55,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001104659-22-008280","document":"tm224689-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465922008280/tm224689-3_4seq1.xml","form_type":"4"}},{"id":2805647,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2021-03-05T22:46:33.000Z","date":"2021-03-04","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of shares available under Cellectar's equity incentive plans at Cellectar's 2021 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":450000,"derivative":{"exercise_price":1.74,"expiration_date":"2021-03-04","underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001104659-21-032852","document":"tm218888d2_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465921032852/tm218888d2_4.xml","form_type":"4"}},{"id":2931110,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-12-28T21:31:13.000Z","date":"2020-12-28","kind":"purchase","acquired":true,"shares":29630,"price":1.35,"value":40000.5,"ownership":{"direct":true},"balance_after":102148,"source":{"system":"sec-edgar","filing":"0001104659-20-139786","document":"tm2039438d2_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920139786/tm2039438d2_4.xml","form_type":"4"}},{"id":3118435,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series H Warrants","published_at":"2020-06-08T20:08:18.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":32609,"price":0.01,"value":326.09,"ownership":{"direct":true},"balance_after":32609,"derivative":{"exercise_price":1.2075,"exercise_date":"2020-06-05","expiration_date":"2025-06-05","underlying":"Common Stock","underlying_shares":32609},"source":{"system":"sec-edgar","filing":"0001104659-20-070839","document":"tm2022064d1_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920070839/tm2022064d1_4.xml","form_type":"4"}},{"id":3118434,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-06-08T20:08:18.000Z","date":"2020-06-05","kind":"purchase","acquired":true,"shares":65218,"price":1.145,"value":74674.61,"ownership":{"direct":true},"balance_after":72518,"source":{"system":"sec-edgar","filing":"0001104659-20-070839","document":"tm2022064d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920070839/tm2022064d1_4.xml","form_type":"4"}},{"id":3224354,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2020-03-05T21:01:51.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Form 4/A is being filed to correct a Form 4 filed on February 4, 2020, in which the stock option grant was reported as a common stock grant. The underlying value of the award remains unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock options vest in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023."}],"balance_after":40000,"derivative":{"exercise_price":2.71,"expiration_date":"2030-02-03","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001104659-20-029695","document":"tm2011832d1_4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920029695/tm2011832d1_4a.xml","form_type":"4/A","original_submission_date":"2020-02-04"}},{"id":3291137,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common stock","published_at":"2020-02-04T21:01:49.000Z","date":"2020-02-03","kind":"grant","acquired":true,"shares":40000,"price":2.71,"value":108400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common stock grant that vests in equal annual increments on February 3, 2021, February 3, 2022, and February 3, 2023."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001104659-20-010610","document":"tm206696d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000110465920010610/tm206696d3_4.xml","form_type":"4"}},{"id":3622961,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2019-03-01T21:20:44.000Z","date":"2019-02-28","kind":"purchase","acquired":true,"shares":100,"price":2.0025,"value":200.25,"ownership":{"direct":true},"balance_after":7300,"source":{"system":"sec-edgar","filing":"0001144204-19-011646","document":"tv515197_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420419011646/tv515197_4.xml","form_type":"4"}},{"id":3691708,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2019-01-18T21:18:19.000Z","date":"2019-01-17","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant is a contingent grant subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the grant shall vest over a period of three years from the grant date, with 1/3 vesting on the first anniversary of the grant date and the remainder vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":30000,"derivative":{"exercise_price":1.99,"expiration_date":"2029-01-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001144204-19-002090","document":"tv511259_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420419002090/tv511259_4.xml","form_type":"4"}},{"id":3790565,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-10-15T23:47:54.000Z","date":"2018-10-12","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option grant was divided into a definitive grant of 29,820 shares, which vest as to all shares on the first anniversary of the grant date, and a contingent grant of 33,180 shares, which are subject to the following conditions: (i) approval by Cellectar's stockholders of an increase in shares available under the Amended and Restated 2015 Stock Incentive Plan at the Corporation's 2019 annual meeting of stockholders or other special meeting of stockholders called for such purpose; and (ii) to the extent stockholder approval is received, the contingent grant shall vest over a period of three years from the grant date, vesting in 24 equal monthly installments over a 24 month period beginning on the first anniversary of the grant date."}],"balance_after":63000,"derivative":{"exercise_price":2.61,"expiration_date":"2028-10-12","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001144204-18-053875","document":"tv504838_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418053875/tv504838_form4.xml","form_type":"4"}},{"id":3839784,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-08-17T22:14:36.000Z","date":"2018-08-16","kind":"purchase","acquired":true,"shares":500,"price":2.71,"value":1355.0,"ownership":{"direct":true},"balance_after":7200,"source":{"system":"sec-edgar","filing":"0001144204-18-045405","document":"tv501325_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418045405/tv501325_form4.xml","form_type":"4"}},{"id":3996135,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2018-03-14T20:01:32.000Z","date":"2018-03-13","kind":"sale","acquired":false,"shares":13000,"price":1.1844,"value":15397.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 29, 2017 to satisfy tax withholding obligations upon vesting of restricted stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 of Line 1 with respect to the 13,000 shares sold on March 13, 2018 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.17 to $1.21. The Reporting Person has provided to the Issuer, and undertakes to provide to any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in Footnote (2) to this Form 4."}],"balance_after":67000,"source":{"system":"sec-edgar","filing":"0001144204-18-014639","document":"tv488454_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420418014639/tv488454_4.xml","form_type":"4"}},{"id":4202378,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-09-25T20:02:59.000Z","date":"2017-09-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in equal quarterly increments over a period of three years from the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":1.83,"expiration_date":"2027-09-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001144204-17-049455","document":"v475738_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420417049455/v475738_4.xml","form_type":"4"}},{"id":4348559,"issuer":{"id":7572,"kind":"organization","name":"Cellectar Biosciences, Inc."},"owners":[{"id":31407,"kind":"person","name":"Longcor Jarrod","position":1,"cik":"0001545565","reported_name":"Longcor Jarrod","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP of Corp Dev & Ops"}}],"security":"Common stock","published_at":"2017-04-20T22:01:39.000Z","date":"2017-04-18","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common stock grant that vests in equal annual increments on March 2, 2018, March 2, 2019, and March 2, 2020."}],"balance_after":80000,"source":{"system":"sec-edgar","filing":"0001144204-17-021330","document":"v464725_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1279704/000114420417021330/v464725_form4.xml","form_type":"4"}}]}